P2RX7 Down (Gene Set)

Analyze

Playbook Workflow Builder
Playbook Workflow Builder: Gene Set Enrichment

Perform Gene Set Enrichment with this gene set against Common Fund program's gene sets, identifying significant overlaps using a pre-built PWB workflow. Run the workflow with P2RX7 Down.

GeneSetCart
GeneSetCart

GeneSetCart helps you to fetch gene sets from various data sources, augment, combine with set operations, visualize and analyze these gene sets in a single session. Start a new session with P2RX7 Down.

CFDE-GSE
CFDE Gene Set Enrichment (GSE)

CFDE-GSE illuminates connections between the input gene set and various CF gene sets that overlap with the queried gene set. Query CFDE-GSE with P2RX7 Down.

Playbook Workflow Builder
Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with P2RX7 Down.

Results found

Linked to

 

Label

Description

 

Gene

ENSG00000169692 - 1-acylglycerol-3-phosphate O-acyltransferase 2

Gene

ENSG00000105289 - tight junction protein 3

Gene

ENSG00000005102 - mesenchyme homeobox 1

Gene

ENSG00000010319 - semaphorin 3G

Gene

ENSG00000120820 - glycosyltransferase 8 domain containing 2

Gene

ENSG00000113396 - solute carrier family 27 member 6

Gene

ENSG00000169282 - potassium voltage-gated channel subfamily A regulatory beta subunit 1

Gene

ENSG00000129048 - atypical chemokine receptor 4

  • Gene

    ENSG00000169692 - 1-acylglycerol-3-phosphate O-acyltransferase 2


  • Gene

    ENSG00000105289 - tight junction protein 3


  • Gene

    ENSG00000005102 - mesenchyme homeobox 1


  • Gene

    ENSG00000010319 - semaphorin 3G


  • Gene

    ENSG00000120820 - glycosyltransferase 8 domain containing 2


  • Gene

    ENSG00000113396 - solute carrier family 27 member 6


  • Gene

    ENSG00000169282 - potassium voltage-gated channel subfamily A regulatory beta subunit 1


  • Gene

    ENSG00000129048 - atypical chemokine receptor 4

  • DISPLAY PER PAGE
    This repository is under review for potential modification in compliance with Administration directives.